NEU neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-145

  1. 6,297 Posts.
    lightbulb Created with Sketch. 22343
    Interesting that today’s webinar was introduced by Gerry Zhao, Neuren’s VP of Corporate Development.

    Gerry was the chief negotiator behind Neuren’s ROW deal for DayBue, announced in July this year. At the time, he was specifically thanked by Jon Pilcher for having “worked tirelessly” to achieve a great outcome.

    Gerry didn’t say much today.

    He really didn’t need to....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.